Related by context. All words. (Click for frequent words.) 77 Receives Patent 76 Files Patent Application 75 Awarded Patent 75 Begins Shipment 73 Receives Certification 73 Successfully Concludes 73 Announces Licensing Agreement 72 Formalizes 72 Introduces Breakthrough 72 Sign Licensing Agreement 72 Spins Out 72 Introduces Next Generation 72 Further Strengthens 72 Commercializes 72 Files Patent 72 Obtains Approval 72 Strengthens Position 72 Achieves ISO #:# Certification [002] 72 Finalizes Acquisition 72 Confirms Commitment 71 Signs Licensing Agreement 71 Completes Successful 71 Announce Collaboration Agreement 71 Ink Pact 71 Unveils Revolutionary 71 Fortifies 71 Introduces Revolutionary 71 Develop Next Generation 71 Submits Application 71 Announces FDA Clearance 71 Terminates Contract 71 Sign License Agreement 70 Expands Capabilities 70 Expands Capacity 70 Achieves Significant 70 Strengthens Its 70 Receives Favorable 70 Significantly Increases 70 Forges Ahead 70 Develops Novel 70 Patent Issued 70 Provides Update Regarding 70 Achieves Milestone 70 Successfully Demonstrates 70 Enters Into Exclusive 70 Obtains Exclusive License 70 Makes Strides 70 Successfully Tests 70 Receives Approval From 70 Announce Successful Completion 70 Achieves ISO # 70 Announce Formation 70 Broadens Its 70 Announce Availability 70 Receives FDA Clearance 70 Subsidiary Enters 70 Announce License Agreement 70 Acquires Controlling Interest 70 Expands Portfolio 70 Secures Patent 70 Introduces Innovative 70 Successfully Completed 70 Inks Licensing Deal 70 Regains Nasdaq 70 Expert Discusses 70 Expands Scope 70 Announces Divestiture 70 Furthers 69 Releases Next Generation 69 Obtains Exclusive 69 Files IND 69 Restructures Debt 69 Streamlines Operations 69 Completes Restructuring 69 Concludes Successful 69 Receives Notification 69 Signs Pact 69 Successfully Tested 69 Announces Initiation 69 Completes Transition 69 Submits Proposal 69 Manufacturer Selects 69 Accelerate Commercialization 69 Announces License Agreement 69 Introduces Novel 69 Unveils Next Generation 69 Outlines Strategy 69 Jointly Develop 69 Regains Full 69 Completes Divestiture 69 Licenses Patents 69 Reconfirms 69 Extends Collaboration 69 Announce Completion 69 Announces Immediate Availability 69 Continues Aggressive 69 Receives NASDAQ 69 Achieves Breakthrough 69 Announces Successful Completion 69 Jointly Announce 69 Appoints Experienced 69 Extends Reach 69 Forges Partnership 69 Launches Next Generation 69 Acquires Exclusive 69 Enters Agreement 69 Regains NASDAQ 69 Proves Successful 69 Awarded Contracts 69 Announces Formation 68 Files Shelf Registration Statement 68 FDA Clears 68 Complies With 68 Announce Agreement 68 Announces Expanded 68 Completes Reverse Merger 68 Receives Clearance 68 Announce Licensing Agreement 68 Receives Favorable Ruling 68 Successfully Completes 68 Announces Shareholder Approval 68 Board Authorizes 68 Completes Integration 68 Spins Off 68 Subsidiary Acquires 68 Jointly Launch 68 Amends Agreement 68 Successfully Passes 68 Develops Innovative 68 Awarded Patents 68 Signs Agreements 68 Receives Orphan Drug Designation 68 Signs License Agreement 68 Secures Funding 68 Amend Merger Agreement 68 Announces Organizational Changes 68 Receives Confirmation 68 Issues Guidance 68 Taglich Brothers Initiates Coverage 68 Enters Joint Venture 68 Files Patent Infringement 68 Sees Continued 68 Sharpens Focus 68 Completes Merger With 68 Extend Partnership 68 Signs MOU 68 Unveils Groundbreaking 68 Successfully Deploys 68 Significantly Improves 68 Platform Enables 68 Signs Merger Agreement 68 Announces Enhancements 68 Unveils Innovative 68 Settles Patent Litigation 68 Unveils Breakthrough 68 Introduces Enhanced 68 Unveils Latest 68 Subsidiary Enters Into 68 Reaffirms Commitment 68 Completes Initial 68 Strengthens Presence 68 Announce Commencement 68 Provides Updates 68 Updates Shareholders 68 Successfully Launches 68 Receives Authorization 68 Attains 68 Restructures Operations 68 Provides Guidance 67 Develops Breakthrough 67 Successfully Integrates 67 Receives Approvals 67 Announces Issuance 67 Receives Commitment 67 Provides Shareholder 67 Named Exclusive Distributor 67 Subsidiary Receives 67 Increases Presence 67 Announces Dismissal 67 Reduces Risk 67 Enters Negotiations 67 Completes Patient Enrollment 67 Shareholders Approve Acquisition 67 Discontinues 67 Consummates 67 Announce Collaboration 67 Announces Termination 67 Shows Promise 67 Announces Stockholder Approval 67 Broadens Product 67 Reaches Settlement Agreement 67 Demonstrates Commitment 67 Complete Merger 67 Affirms Commitment 67 Launches Breakthrough 67 Aquires 67 Develops Next Generation 67 Wins Summary Judgment 67 Provides Clarification 67 Launches Enhanced 67 Repositions 67 Completes Recapitalization 67 Enters Into Agreement 67 Finalizes Agreement 67 Expand Relationship 67 Enters Into Strategic 67 Initiates Clinical Trial 67 Delivers Next Generation 67 Penetrates 67 Enters Into Licensing Agreement 67 Could Revolutionize 67 Introduces Unique 67 Receives Order 67 Diversifies 67 Develop Innovative 67 Re Affirms 67 Inks Deals 67 Wins Patent Infringement 67 Announces Signing 67 Engages CHF Investor Relations 67 Receives Recognition 67 Receives Initial 67 Accelerates Growth 67 Reduces Debt 67 Realigns 67 Amplifies 67 Patents Covering 67 Expand Collaboration 67 Develop Novel 67 Subsidiary Expands 67 Gets FDA Clearance 67 Completes Expansion 67 Retains Leading 67 Expands Distribution 67 Strengthens Commitment 67 Issued Patent 67 Unveils Expanded 67 Settles Litigation 67 Underscores Commitment 67 Moves Towards 67 Sign Definitive Agreement 67 Delivers Breakthrough 67 Secures Financing 67 Ink Deal 67 Settle Patent Dispute 67 Wins Approval 67 Receives Milestone Payment 67 Expands Availability 67 Explore Strategic Alternatives 67 Updates Guidance 67 Unveils Newest 67 Completes Tender Offer 67 Completes Acquisitions 67 Settle Patent Litigation 67 Helps Improve 67 Announces Definitive Agreement 67 Provides Comprehensive 67 Validates 66 Temporarily Suspends 66 Teledyne Acquires 66 Announce Joint Venture 66 Issues Clarification 66 Regains Compliance With 66 Cooperates 66 Expands Presence 66 Buys Majority Stake 66 Acquires Assets 66 Board Unanimously Rejects 66 Updates Status 66 Initiates Clinical 66 Announce Expanded 66 Terminates Agreement 66 Achieves Prestigious 66 Clears Path 66 Issues Statement Regarding 66 Reach Settlement Agreement 66 Renews Agreement 66 Strengthens Leadership 66 Announces Acquisition 66 Awarded Contract Extension 66 Makes Headway 66 Licenses Novel 66 Receives Conditional 66 Reorganizes 66 Formally Launches 66 Finalizes Sale 66 Refocuses 66 Receives Approval 66 Announces Discontinuation 66 Report Indicates 66 Ships #th 66 Gets Clearance 66 Settle Litigation 66 Demonstrates Next Generation 66 Doubles Capacity 66 Files Petition 66 Achieves Highest 66 Strengthens Balance Sheet 66 Enters Strategic 66 Announces Cancellation 66 Remains Committed 66 Announces Favorable Ruling 66 Announces Additions 66 Announce Launch 66 Inks Pact 66 Dramatically Increases 66 Announce Breakthrough 66 DayTradersDigest.com Profiles 66 Finalize Joint Venture 66 Extends Commitment 66 Achieves Record Sales 66 Subsidiary Completes 66 Receives Notice From 66 Announces Intent 66 Retains CCG Investor Relations 66 Q2 Loss Narrows 66 Procures 66 Terminates Merger Agreement 66 Builds Momentum 66 Receives CE Marking 66 Pending Acquisition 66 Seeks Approval 66 Identifies Potential 66 Announce Settlement 66 Executes Agreement 66 Thewallstreetleader.com Profiles 66 Photovoltaic Module 66 Regains Compliance 66 Receives ISO #:# [001] 66 Achieves Certification 66 Confirms Receipt 66 Expands Reach 66 Finalize Agreement 66 Commenced Against 66 Resolves Dispute 66 Enables Rapid 66 Further Validates 66 Reports Positive 66 Establish Joint Venture 66 Differentiates 66 Could Trigger 66 Provide Comprehensive 66 Signs Distribution 66 Completes Purchase Of 66 Unsolicited Proposal From 66 Receives Subpoena 66 Buy Privately Held 66 Obtains Exclusive Rights 66 Announces Commencement 66 Takes Majority Stake 66 Announces Stock Buyback 66 Debuts Next Generation 66 Acquire Assets 66 Furthers Commitment 66 Acquire Majority Stake 66 Reduces Cost 66 Seeks Proposals 66 Successfully Closes 66 Doubles Size 66 Enters Into License Agreement 66 Signs Definitive Agreement 66 Announce Merger Agreement 66 Expands Globally 66 Improves Productivity 66 Extend Collaboration 66 Launches Redesigned Website 66 Gets Subpoena 66 Secures Contract 66 Receives Notice 66 Ramps Up Production 66 Gathers Momentum 66 Completes Reorganization 66 Completes Conversion 66 Settles Patent Dispute 65 Announces Rebranding 65 Releases Findings 65 Announce Receipt 65 Completes Purchase 65 Announces Publication 65 Signs Agreement 65 Reacquires 65 Implant Sciences Announces 65 Patent Covering 65 Completes Refinancing 65 Successfully Completes Phase 65 Reaches Agreement 65 Q2 Loss Widens 65 Marks Milestone 65 Report Analyzes 65 Reshapes 65 Completes Merger 65 Announce Definitive Agreement 65 Patents Issued 65 Emphasizes Importance 65 Helps Prevent 65 Receives Regulatory 65 Completes Previously Announced 65 High Growth Forecasted 65 Expert Joins 65 Subsidiary Signs 65 Reports Receipt 65 Completes Installation 65 Jumps Higher 65 Awarded Subcontract 65 & Sullivan Recognizes 65 Provides Updated 65 Announces Receipt 65 Announces Repurchase 65 Reinforces Commitment 65 Introduces Expanded 65 Approves Merger 65 Closes Sale 65 Broadens 65 Sees Steady 65 Emphasizes Need 65 Receives Unsolicited 65 Receives Notification From 65 Q3 Loss Widens 65 Ceases 65 Approves Share Repurchase 65 Awarded Multi 65 Retains Investor Relations 65 Significantly Expands 65 Announces Sponsorship 65 Awarded Contract 65 Receives Positive 65 Reaches Pact 65 Initiates Enrollment 65 Holds Promise 65 Announces Effective Date 65 Sees Significant 65 Shifts Focus 65 Withdraws Offer 65 Concerns Arise 65 Provides Unprecedented 65 Initiates Phase II 65 Introduces Groundbreaking 65 Finalizes Purchase 65 Receives Funding 65 Addresses Growing 65 Settles Patent Infringement Lawsuit 65 Enters Into Joint Venture 65 Abandons Plans 65 Merger Creates 65 Receives SFDA Approval 65 Takes Stake 65 Subsidiary Wins 65 Sign Reseller Agreement 65 Announces Reseller Agreement 65 Expanding Presence 65 Announces Favorable 65 Enables Easy 65 Q1 Loss Widens 65 Increases Capacity 65 Commercialize 65 Broadens Scope 65 Enters Into Definitive Agreement 65 Submits NDA 65 Maintains Strong 65 Enters Into Definitive 65 Completes Transaction 65 Results Confirm 65 Q3 Loss Narrows 65 Expands Commitment 65 Achieves Milestones 65 Demonstrate Innovative 65 Clarifies Status 65 Releases Enhanced 65 Renegotiates 65 Submits IND 65 Settles Dispute 65 Presents Preclinical Data 65 Heightens 65 Concludes Acquisition 65 Awarded GSA Schedule 65 Study Shows Benefits 64 Investigates Possible 64 Initiates Dosing 64 Gets Approval 64 Bodes Well 64 Announces Spin Off 64 Announce Initiation 64 Establishes Presence 64 Announces Stock Repurchase 64 Obtains License 64 Settles Patent Suit 64 Rated Speculative Buy 64 Ups Ante 64 Becomes Exclusive Distributor 64 Files Shelf Registration 64 Completes Enrollment 64 Revitalizes 64 Settle Patent 64 Blood Clotting 64 Highlights Importance 64 Licensing Pact 64 Awarded GSA 64 Completes Asset 64 Renews Commitment 64 Expand Presence 64 Deaths Prompt 64 Outlines Vision 64 Subsidiary Files 64 StockSource.us Reports 64 Increases Ownership 64 Introduces Ultra Low 64 Collaborates With 64 Shares Plummet 64 Successfully Implements 64 Files Provisional 64 Boosts Productivity 64 Increases Efficiency 64 Awarded Prestigious 64 Present Preclinical Data 64 Enrolls First 64 Submits Bid 64 Report Examines 64 Launches Innovative 64 Establishes Joint Venture 64 Announces Share Repurchase 64 Successfully Complete 64 Forges Strategic 64 Delivers Strong 64 Reinforces Leadership 64 Pushes Ahead 64 Expand Into 64 Demonstrates Significant 64 Momentum Continues 64 Immunomedics Announces 64 Attracts Attention 64 Stockholders Approve Acquisition 64 Completes Financing 64 Secures Long Term 64 Obtains Financing 64 Announces Presentation 64 Acquires Remaining Interest 64 Announces Filing 64 Launches Unique 64 Monetizes 64 Reaches Settlement 64 Distribution Pact 64 Announces Postponement 64 Showcases Innovative 64 Speeds Up 64 Centralizes 64 Q4 Loss Widens 64 Closes Previously Announced 64 Refines 64 Hires Lobbyist 64 Finds Evidence 64 Scientists Develop 64 Subsidiary Awarded 64 Announces Addition 64 Announces Intention 64 Being Studied 64 Releases Latest 64 Extend Relationship 64 Presents Positive 64 Closes Merger 64 Flamel Technologies Announces 64 Announces Revised 64 Establishes Strategic 64 Helps Predict 64 Directors Authorizes 64 Daytradersdigest.com Profiles 64 Announces Share Buyback 64 Receives Marketing Authorization 64 Achieves ISO #:# Certification [001] 64 Provides Preliminary 64 Receives Orphan Drug 64 Taps Lobbyist 64 Retools 64 Extends Relationship 64 Pursues 64 Reports Significantly Improved 64 MarketResearch.com Announces 64 Stays Neutral 64 Expands Into 64 Inks MOU 64 Delivers Enhanced 64 Inks LOI 64 Rapidly Expanding 64 Hits Milestone 64 Continues Commitment 64 Restructures 64 Dramatically Expands 64 Successfully Delivers 64 Enters Into Long Term 64 Files Lawsuit Against 64 Sells Remaining 64 Releases Latest Version 64 Q4 Loss Narrows 64 Expands Relationship With 64 Reports Profitable 64 Unveils Enhanced 64 Gene Expression Analysis 64 Completes Acquisition 64 Signs Reseller Agreement 64 Consolidates Operations 64 Study Indicates 64 Announces Successful 64 Gaining Momentum 64 Wins Contract 64 Deliver Powerful 64 Helps Identify 64 Authorizes Stock Repurchase 64 ARRIS Announces 64 Announces Restatement 64 Receives Delisting Notice 64 Demonstrate Breakthrough 64 Prove Effective 64 Study Identifies 64 Demonstrates Interoperability 64 Provides Complete 64 Enters Into Settlement Agreement 64 Successfully Completes Tender Offer 64 Finalizes Contract 64 Provider Selects 64 Settles Patent 64 Enter Into 64 Expands Internationally 64 Launches Expanded 64 Significantly Enhances 64 Commences Cash 64 Shareholder Sues 64 Expands Offerings 64 Inks Contract 64 Solidifies 64 Signs Purchase Agreement 64 Nanoimprint Lithography 64 Collaborators Publish 64 Successful Completion 64 Sinks Lower 64 Announces Adjournment 64 Shareholders Approve Merger 64 Expands Scientific Advisory 63 Files Suit Against 63 Announces Expansion 63 Gathers Steam 63 Stockholders Approve Merger 63 Announces Refinancing 63 NEC Develops 63 Signs Definitive 63 Continues Momentum 63 Must Rethink 63 Flagship Product 63 Receives ISO #:# [002] 63 Announces Preliminary 63 Markettelegraph.com 63 Settles Charges 63 Discloses 63 Substantially Increases 63 Achieves Record Revenue 63 Successfully Completes Acquisition 63 Enhances Functionality 63 Closes Acquisition Of 63 Shares Surge 63 Shows Promise Against 63 Momentum Grows 63 Expands Coverage 63 Reinforces 63 Hires Experienced 63 Demonstrates Improved 63 Announces Profitable 63 Announces Availability 63 Completes Buyout 63 Signs Memorandum 63 Celebrates Successful 63 Tumor Targeting 63 Concerns Raised 63 Annouces 63 Anounces 63 Misonix Announces 63 Launches Groundbreaking 63 Holds Successful 63 Achieves ISO 63 Protein Synthesis 63 Patent Disputes 63 Enters Into Letter 63 Receives Accreditation 63 Beefs Up 63 FY# Loss Widens 63 Increases Stake 63 Taps Into 63 Demonstrate Latest 63 Q1 Loss Narrows 63 Forms Joint Venture 63 Jointly Explore 63 Expands Footprint 63 Gains Momentum 63 Strengthen Relationship 63 Takes Steps 63 Revolutionises 63 Restate Financials 63 Withdraws Proposal 63 Signs LOI 63 Underpins 63 Assets Acquirer Company 63 Unveils Powerful 63 Extends Relationship With 63 Multi Billion Dollar 63 Dramatically Improves 63 Receives Prestigious 63 Appoints Seasoned 63 Receives Endorsement 63 BIOLASE Announces 63 Cuts Costs 63 Commences Initial 63 Signs LoI 63 Deepens 63 Strengthens Relationship 63 Confirms Efficacy 63 Reduces Size 63 Fine Tunes 63 Earnings Postmortem 63 Signs Definitive Agreements 63 Outlines Steps 63 Confirms Significant 63 Closes Acquisition 63 Paves Way 63 Selects Kofax 63 Increases Commitment 63 Begins Shipping 63 Propels 63 Receives Prestigious Award 63 Announces Completion 63 Boosts Buyback 63 Continues Rapid 63 Directors Elects 63 Enables Faster 63 Extends Leadership 63 Extends Capabilities 63 Inks License 63 Receives Highest 63 Reach Settlement 63 Signs Binding 63 Files Resale 63 Completes Sale 63 Receives Notice Regarding 63 Liquidates 63 Settle Dispute 63 Files Amended 63 Announces Resumption 63 Software Simplifies 63 Demonstrates Latest 63 Showcases Latest 63 Achieves Record 63 Sign Pact 63 Accredits 63 Announces Positive 63 Boosts Guidance 63 Registration Statement Declared Effective 63 Revolutionizes 63 Naturally Occurring 63 Raises Concerns 63 Progresses 63 Significantly Reduces 63 Elevates 63 Study Proves 63 Secures Additional 63 Shares Soar 63 Shares Climb 63 Summarizes 63 Inks Distribution 63 Carries Out 63 Complies 63 Receives Approvable Letter 63 Acquisition Strengthens 63 Boosts Capacity 63 Milestone Reached 63 Strongly Supports 63 Mutually Agree 63 Toshiba Develops 63 Stays Ahead 63 Announcement Regarding 63 Positions Itself 63 Rebrands 63 Engages Investor Relations 63 BioSante Pharmaceuticals Announces 63 Undertakes 63 Lays Groundwork 63 Reiterates Support 63 Acknowledges Receipt 63 Adds Depth 63 Unveil Latest 63 Brings Expertise 63 Growing Rapidly 63 Demonstrates Long Term 63 Approves Stock Repurchase 63 Exclusive Licensee 63 Eliminates Need 63 Extends Maturity 63 Nears Completion 63 Initiates 63 Completes Private Placement 63 Fujitsu Develops 63 Successfully Implemented 63 Sets Record Date 63 Reaffirms Support 63 Study Reinforces 63 Sniffs Out 63 Showcases Next Generation 63 Accepted Into 63 Announces Recapitalization 63 Gains Ground 63 Bolsters 63 Exploring Strategic Alternatives 63 Revolutionise 63 Evolves 63 Closes Buyout 63 Report Assesses 63 Introduces Newest 63 Finalizes 63 Recommends Changes 63 Redesigns Website 63 Files Patent Infringement Lawsuit 63 Moves Ahead 63 Posts Strong 63 Signs MoU 63 - Aarkstore Enterprise [002] 63 AnaSpec Introduces 63 Helps Ensure 63 Significantly Expand 63 Expands 63 Receives Stockholder Approval 62 Sets Stage 62 Receives Regulatory Approvals 62 Delists 62 Subsidiary Purchases 62 ANADIGICS Announces 62 Reiterates Commitment 62 Files Countersuit Against 62 AllPennyStocks.com Spotlights 62 Deliver Integrated 62 Improves Efficiency 62 Changes Name 62 Enters Definitive Agreement 62 Acquire Majority 62 Becomes Newest 62 Revises Fourth Quarter 62 Acquires Majority Stake 62 Announces Consummation 62 Signs Exclusive 62 Presents Positive Preclinical 62 License Pact 62 Magazine Recognizes 62 Expedites 62 Announces Proposed 62 Sells Shares 62 Continues Steady 62 Improves Customer 62 Accelerates Expansion 62 Has Commenced 62 Reveals Receipt 62 Quadruples 62 Making Inroads 62 Sees Positive 62 Offers Enhanced 62 Announces Reverse Split 62 Acquires Majority 62 Announce Interoperability 62 Obtains 62 Surpasses Expectations 62 Files Definitive Proxy 62 Gains Foothold 62 Files Preliminary Proxy 62 Announces Departure 62 Extends Tender Offer 62 Expects Higher 62 Ramps Up 62 Becomes Largest 62 Finalizes Merger 62 Migrates 62 Achieves SAS 62 Sounds Alarm 62 Pave Way 62 Patent Infringement 62 Molecular Diagnostic Test 62 Announces Ticker Symbol 62 Bulks Up 62 Clarifies Position 62 Earns ISO #:# 62 Seek Shareholder Approval 62 Patent Lawsuit 62 Delivers Comprehensive 62 Recertified 62 Experts Urge 62 Issues Shareholder 62 Reaches Settlement With 62 Tessera Licenses 62 Settle Dispute Over 62 Deliver Presentation 62 Resubmits 62 Dry Powder Inhalers 62 Authorizes Additional 62 Shortage Threatens 62 Ventures Invests 62 Outlines Plans 62 Pathogen Detection 62 Attracting Bullish Investors 62 Files Registration Statement 62 Enters Into Agreements 62 Cautions Against 62 Acquire Stake 62 Winning Streak Continues 62 Jointly Developed 62 Downsizes 62 Protects Customers 62 Has Been Awarded 62 Reaches Tentative Settlement 62 Earns Recognition 62 Makes Unsolicited Bid 62 Morphs Into 62 Closes Financing 62 Settles Dispute With 62 Faces Obstacles 62 Announce Merger 62 Jointly Offer 62 Could Prevent 62 Lowers Guidance 62 Patents Upheld 62 Identifies Key 62 Wins Prestigious Award 62 Releases Newest Version 62 Shows Promising 62 Aligns 62 Jumpstarts 62 Initiates Clinical Trials 62 TSX Delisting Review 62 Sees Continued Growth 62 Enters Into Collaboration 62 Announce Licensing 62 Earns Certification 62 Moves Toward 62 Files Annual Report 62 Q1 Profit Surges 62 Announces Expiration 62 Protects Against 62 Commences Trading 62 Launches Website 62 Reaffirm Commitment 62 Voices Concern 62 Q1 Adj 62 VP Exercises Options 62 Signs Long Term 62 Deliver Enhanced 62 Accelerates 62 & Sullivan Lauds 62 Widens 62 Expresses Concern Over 62 Signs Non Binding 62 Patent Dispute 62 Demystifies 62 Inks Deal With 62 Guides Inline 62 Motorola Invests 62 Wolf Haldenstein Investigating 62 Joins Hands 62 Autodesk Completes Acquisition 62 Earns Top 62 Named Fastest Growing 62 Advises Against 62 Wafer Manufacturing 62 Patent Infringement Lawsuit Against 62 Opens Door 62 Amends Terms 62 Commences Phase 62 Outlines Goals 62 Keeps Growing 62 Patent Upheld 62 Reveals Significant 62 Q4 Profit Plunges 62 Lawsuit Filed Against 62 Bearish Speculation 62 Method Developed 62 Solar Wafer 62 Enters Into 62 Inc. OTCBB MNDP 62 Explores Strategic Alternatives 62 Lauches 62 Confirms Validity 62 Expands Functionality 62 Continues Expansion 62 Announce Partnership 62 Acquire Privately Held 62 Solidifies Position 62 Celebrates Tenth Anniversary 62 Demonstrates Potential 62 Adds Seasoned 62 STERIS Corporation Announces 62 Acquires 62 Drug Candidate 62 Augments 62 Q4 Profit Decreases 62 Announces Underwriters Exercise 62 Study Examines 62 Announces Keynote Speakers 62 Successfully Demonstrated 62 Reinforces Its